©The Author(s) 2025.
World J Gastroenterol. Nov 28, 2025; 31(44): 112833
Published online Nov 28, 2025. doi: 10.3748/wjg.v31.i44.112833
Published online Nov 28, 2025. doi: 10.3748/wjg.v31.i44.112833
Figure 1 Dexmedetomidine promoted postoperative intestinal recovery.
A: Intestinal propulsion rate on postoperative day 6 (n = 6 per group). No significant differences were observed among groups; B: Anastomotic bursting pressure on postoperative day 7 (n = 6 per group); C: Representative hematoxylin-eosin-stained sections of the colon. Intestinal anastomosis (IA) group: Inflammatory cell infiltration (arrows) and edema (circles) in epithelium/crypt regions; Disorganized epithelium. IA + dexmedetomidine (DEX) group: Reduced inflammation and epithelial thickness; D: Representative Masson’s trichrome-stained sections demonstrating collagen deposition (IA + DEX > IA). Original magnification: 400 ×; scale bar: 50 μm. bP < 0.01. cP < 0.001. 1P compared with the Sham group. 2P compared with the intestinal anastomosis group. DEX: Dexmedetomidine; IA: Intestinal anastomosis; Sham group: Underwent abdominal only opening and closure; IA + DEX group: Dexmedetomidine was infused in the intestinal anastomosis model.
- Citation: Chen Y, Li CT, Wang JB, Tang WL, Zhao Y, Chen Y, Liao LM, Zhang LC, Lin TH, Cao ZF. Dexmedetomidine enhances anastomotic healing partly via the Wnt/β-catenin pathway in a rat model of colon surgery. World J Gastroenterol 2025; 31(44): 112833
- URL: https://www.wjgnet.com/1007-9327/full/v31/i44/112833.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i44.112833